The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease

NCT03829046 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Vascular Disease
Type2 Diabetes
Microvascular Dysfunction

Interventions

DRUG: Placebo
DRUG: Evolocumab

Sponsor

Robert Rosenson

Collaborators

[object Object]
[object Object]
[object Object]